Figure 6.
The gene sets positively correlated with EIF4A1 contribute to cancer cell growth and immunity suppression. The GSVA score of the gene set positively correlated with EIF4A1, sub-grouped by normal and tumor tissues (A) and clinical stages (B). The survival associations using different outcome indicators in high- or low-GSVA score patients of LUAD (C). KEGG pathway of the gene set positively correlated with EIF4A1 (D). Pathway analysis of the gene set positively correlated with EIF4A1 in the canonical pathway (E) and disease and function (F), as assessed via IPA. The correlation of immune cell infiltration with the GSVA score of the gene set positively correlated with EIF4A1 (G). ****: p < 0.001.
